BDBM575872 2-{2-[4-(1,2-Benzoisoxazol-3-yl)piperazin-1-yl]ethyl}-6-methyl-3,4-dihydro-2,7-naphthyridin-1(2H)-one::US11466007, Example 3

SMILES Cc1cnc2C(=O)N(CCN3CCN(CC3)c3noc4ccccc34)CCc2c1

InChI Key InChIKey=SHHOUUFZCQEFDZ-UHFFFAOYSA-N

Data  3 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 575872   

Target5-hydroxytryptamine receptor 2A(Human)
Sumitomo Pharma

US Patent
LigandPNGBDBM575872(US11466007, Example 3 | 2-{2-[4-(1,2-Benzoisoxazol...)
Affinity DataKi:  2.30nMAssay Description:Binding inhibition rate for 5-HT1A receptor (%)=100−100×{(Binding amount of [3H]8-OH-DPAT in the presence of test compound)}−(Binding amount of [3H]8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/12/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Sumitomo Pharma

US Patent
LigandPNGBDBM575872(US11466007, Example 3 | 2-{2-[4-(1,2-Benzoisoxazol...)
Affinity DataKi:  2.30nMAssay Description:Present compound for human 5-HT1A receptor, human 5-HT2A receptor, and human D2 receptor was measured by the following procedures. CHO cell membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 1A(Human)
Sumitomo Pharma

US Patent
LigandPNGBDBM575872(US11466007, Example 3 | 2-{2-[4-(1,2-Benzoisoxazol...)
Affinity DataKi:  2.70nMAssay Description:Binding inhibition rate for 5-HT1A receptor (%)=100−100×{(Binding amount of [3H]8-OH-DPAT in the presence of test compound)}−(Binding amount of [3H]8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/12/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 1A(Human)
Sumitomo Pharma

US Patent
LigandPNGBDBM575872(US11466007, Example 3 | 2-{2-[4-(1,2-Benzoisoxazol...)
Affinity DataKi:  2.70nMAssay Description:Present compound for human 5-HT1A receptor, human 5-HT2A receptor, and human D2 receptor was measured by the following procedures. CHO cell membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2022
Entry Details
US Patent

TargetD(2) dopamine receptor(Human)
Sumitomo Pharma

US Patent
LigandPNGBDBM575872(US11466007, Example 3 | 2-{2-[4-(1,2-Benzoisoxazol...)
Affinity DataKi:  1.26E+3nMAssay Description:Present compound for human 5-HT1A receptor, human 5-HT2A receptor, and human D2 receptor was measured by the following procedures. CHO cell membrane ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2022
Entry Details
US Patent

TargetD(2) dopamine receptor(Human)
Sumitomo Pharma

US Patent
LigandPNGBDBM575872(US11466007, Example 3 | 2-{2-[4-(1,2-Benzoisoxazol...)
Affinity DataKi:  1.26E+3nMAssay Description:Binding inhibition rate for 5-HT1A receptor (%)=100−100×{(Binding amount of [3H]8-OH-DPAT in the presence of test compound)}−(Binding amount of [3H]8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/12/2025
Entry Details
US Patent